NCT01968993 - Comparison of nanOss Bioactive With Autograft and Bone Marrow Aspirate to Autograft in the Posterolateral Spine | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions

Degenerative Disc DiseaseSpinal StenosisSpondylolisthesis

Interventions

DEVICE

nanOss Bioactive - posterolateral gutter

Participants will undergo instrumented PLF at one or two adjacent levels from L2-S1 with PEEK interbody cages (containing allograft or autograft) using nanOss Bioactive in combination with autograft and bone marrow aspirate in the posterolateral gutter on one side. Autograft alone will be used in the opposite posterolateral gutter.

Trial Locations (3)

65201

Columbia Orthopedic Group, Columbia

92037

Scripps Green Hospital, La Jolla

94143

University of California San Francisco, San Francisco